Search Results 121-130 of 2799 for ⚙[광고텔레:TOOPPC] 찌라시배포광고 소액결제 구글찌라시작업광고 구글신용카드현금화홍보 법인통장삽니다 구글오피사이트광고⚙

1. Clinical Outcomes of Patients Treated With Open Surgical Repair for Complex Aortic Aneurysms

   Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and ...

2. CYP2C19 Genotype Predictor of Gastric Acid Suppression - Mayo Clinic

   About this study. If CYP2C19 genotype can predict the efficacy of healing erosive esophagitis and gastric acid secretion in patients taking once a day ...

3. William M. Stone, M.D. - Mayo Clinic Faculty Profiles

   Mayo Clinic researcher William M. Stone, M.D., is a vascular surgeon with expertise in open and endovascular surgery.

4. A Study to Analyze Fractures and Bone Disease in Living Kidney Donors - Mayo Clinic

   This information will be valuable in informing future kidney donors of the risks of donation and in devising treatments, such as administration of vitamin D ...

5. Collaborators - Genome Function, Stability and Nuclear Organization in Cancer: Veronica Rodriguez-Bravo - Mayo Clinic Research

   Dr. Veronica Rodriguez-Bravo engages in research collaborations with other Mayo Clinic investigators.

6. A Study of Clinical and Radiologic Characteristics and Outcomes in Patients with Myelopathy Associated with Idiopathic Focal Displacement on MRI

   The purpose of this study is to investigate the clinical presentation, radiological findings, surgical treatment, and the subsequent clinical course and ...

7. Study to Evaluate Safety and Preliminary Efficacy of MOR208 With Idelalisib or Venetoclax in R/R CLL/SLL Patients Pretreated With BTKi (COSMOS) - Mayo Clinic

   About this study. This is a two-cohort, multicenter, open-label study of MOR00208 combined with idelalisib or venetoclax in adult patients with R/R CLL or ...

8. Open-label Study of the Safety and Activity of Oprozomib in Patients With Hematologic Malignancies - Mayo Clinic

   The purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.

9. Effect of Bile Acids on Satiety, Cell Function and Body Weight in Patients With Obesity and Abnormal Satiety Phenotype - Mayo Clinic

   The purpose of this study is to evaluate the effect of IC-CBAS 1000 mg BID on EEC function, weight loss, satiety perception, and satiety GI hormones, in ...

10. Prevalence of Transthyretin Cardiac Amyloidosis in Clinically Significant Aortic Stenosis

    The purpose of this study is to determine the prevalence of TTR-CA in a community-based cohort of moderate and severe aortic stenosis patients using 99mTc-PYP ...